OpGen receives Nasdaq notice for stockholders' equity deficiency; faces potential delisting

CapForce Inc.

Regained bid price compliance on June 5, 2024, but same day notified of stockholders' equity deficiency (need at least $2.5M).
Company submitted response to Nasdaq Hearings Panel on June 11, 2024, with plan to cure deficiency.
No immediate effect on listing, but no assurance of additional time or cure.
Stock symbol OPGN on Nasdaq Capital Market.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.